Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme-Reference-Cited by-同舟云学术

Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme

Published:2013-12 Issue: Volume:70 Page:456-468
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Diez-Torrubia Alberto,Cabrera Silvia,de Castro Sonia,García-Aparicio Carlos,Mulder Gwenn,De Meester Ingrid,Camarasa María-José,Balzarini Jan,Velázquez Sonsoles

Funder

Spanish MEC/MICINN

Comunidad de Madrid

KU Leuven

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference40 articles.

1. Ta1, a novel 105 kDa human T cell activation antigen defined by a monoclonal antibody;Fox;J. Immunol.,1984

2. CD26, let it cut or cut it down;De Meester;Immunol. Today,1999

3. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions and clinical aspects of the enzyme DPPIV;Lambeir;Crit. Rev. Clin. Lab. Sci.,2003

4. Proline-dependent structural and biological properties of peptides and proteins;Yaron;Crit. Rev. Biochem. Mol.,1993

5. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides;Mentlein;Regul. Pept.,1999

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanozyme-activating prodrug therapies: A review;Chinese Chemical Letters;2024-02

2. Prodrugs: Harnessing chemical modifications for improved therapeutics;Journal of Drug Delivery Science and Technology;2023-12

3. Antiviral Peptide-Based Conjugates: State of the Art and Future Perspectives;Pharmaceutics;2023-01-20

4. Peptide-Drug Conjugates: A New Hope for Cancer Management;Molecules;2022-10-25

5. Can the Union of Prodrug Therapy and Nanomedicine Lead to Better Cancer Management?;Advanced NanoBiomed Research;2021-11-05